Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous BM-SC Transplantation in Rheumatoid Arthritis
NCT03067870Phase 1Unknown
- Sponsor
- Stem Cells Arabia
- Start
- Nov 2016
- Primary completion
- Dec 2021
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, open-label, single-arm trial of autologous bone marrow-derived stem cells in rheumatoid arthritis (RA), sponsored by Stem Cells Arabia. Primary endpoint: Evaluation of Pain Reduction measured by VAS scaling at 1 month. Status: unknown.
02
Drugs
autologous bone marrow-derived stem cells
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03067870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03067870.